SMTL ID : 9i0w.1

Structure of human PD-L1 in complex with clinically evaluated inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

homo-dimer

Ligands

1 x 01: (3~{R})-1-[[7-(iminomethyl)-2-[2-methyl-3-[2-methyl-3-[[3-[[(3~{R})-3-oxidanylpyrrolidin-1-yl]methyl]-1,7-naphthyridin-8-yl]amino]phenyl]phenyl]-1,3-benzoxazol-5-yl]methyl]pyrrolidine-3-carboxylic acid

01.1: 27 residues within 4Å: Chain A: F.5, T.6, I.40, Y.42, N.49, Q.52, V.54, M.101, I.102, S.103, A.107, D.108, Y.109, K.110 Chain B: F.5, T.6, V.7, I.40, Y.42, N.49, Q.52, M.101, I.102, S.103, A.107, D.108, K.110 16 PLIP interactions: 10 interactions with chain B, 6 interactions with chain A Hydrophobic interactions: B:I.40, B:Y.42, B:Q.52, B:M.101, B:A.107, A:I.40, A:Y.42, A:M.101 Hydrogen bonds: B:F.5 Salt bridges: B:D.108, B:K.110, A:D.108 pi-Stacking: B:Y.42, B:Y.42, A:Y.42, A:Y.42

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Slota, A. et al., Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for Immunotherapy. Acs Med.Chem.Lett. (2025)

Release Date

2025-06-18

Peptides

Programmed cell death 1 ligand 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Programmed cell death 1 ligand 1

Related Entries With Identical Sequence